Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 29,128 shares at $164.36 ($4.7M) on 2018-03-19, disclosed to the SEC on 2018-03-20.
Open-market sale of $4.7M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.45 | 500 | $79K | 1.7% |
| 2 | $159.62 | 5,200 | $830K | 17.6% |
| 3 | $160.60 | 9,618 | $1.5M | 32.8% |
| 4 | $161.62 | 3,141 | $508K | 10.8% |
| 5 | $162.79 | 5,133 | $836K | 17.8% |
| 6 | $163.48 | 4,636 |
| $758K |
| 16.1% |
| 7 | $164.36 | 900 | $148K | 3.1% |
| Total | $161.46 avg | 29,128 | $4.7M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |